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Abstract
Aims—To evaluate the toxicity and cellular uptake of both undifferentiated and differentiated
human adipose-derived stem cells (hASCs) exposed to silver nanoparticles (Ag-NPs), and to
assess their effect on hASC differentiation.
Materials & methods—hASC were exposed to 10- or 20-nm Ag-NPs at concentrations of 0.1,
1.0, 10.0, 50.0 and 100.0 μg/ml either before or after differentiation down the adipogenic or
osteogenic pathways.
Results—Exposure of hASC to either 10- or 20-nm Ag-NPs resulted in no significant
cytotoxicity to hASC, and minimal dose-dependent toxicity to adipogenic and osteogenic cells at
10 μg/ml. Each of the hASC, adipogenic and osteogenic cells showed cellular uptake of both 10-
and 20-nm Ag-NPs, without causing significant ultrastructural alterations. Exposure to 10- or 20-
nm Ag-NPs did not influence the differentiation of the cells, and at antimicrobial concentrations of
Ag-NPs resulted in a minimal decrease in viability.
Conclusion—The biocompatibility of Ag-NPs with both undifferentiated and differentiated
hASC establishes their suitability for incorporation into tissue-engineered graft scaffolds, for the
prevention of bacterial contamination upon implantation.
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Over 300,000 incidences of surgical-site infection occur annually in the USA, arising in
approximately 2–3% of patients who have undergone surgery. Although rates vary widely
according to the type of surgery, 33% of infections occur from orthopedic surgeries resulting
in increased treatment intensity, prolonged length of stay, higher costs and greater risk for
readmission or death [101]. The most common bacterial strain responsible for surgical
infection is Staphylococcus aureus, and the only method employed currently to avoid
infection is through strict adherence to sterile surgical conditions and through the
administration of prophylactic antibiotics [1]. However, drug-resistant organisms such as
methicillin-resistant S. aureus and vancomycin-resistant enterococci are still problematic [1].
Due to the enhanced antibacterial activity of silver (Ag) at the nanoscale level, Ag-
nanoparticles (NPs) are the most used nanomaterial and the most valuable in the medical
and personal hygiene fields through their incorporation into hundreds of consumer products
[102]. Previous studies have demonstrated that Ag-NPs exert antimicrobial effects on a wide
spectrum of bacteria such as Escherichia coli, Enterococcus faecium, Vibrio cholera, S.
aureus and even methicillin-resistant S. aureus [2–4]. Since Ag compounds have been used
for centuries with a lack of toxicity or carcinogenicity to the immune, cardiovascular,
nervous or reproductive systems, the use of Ag-NPs in products has largely been
unregulated [103]. Presently, there is no consensus on the cytotoxicity of Ag-NPs; however,
the majority of publications do show reduced cell viability and increased reactive oxygen
species generation following Ag-NP exposure [5].
An application for Ag-NPs is their incorporation into implantable materials such as
prostheses and skin or bone grafts. In recent years, tissue engineering of patient-specific
bone grafts has been used to replace damaged or defective tissues, and has become a viable
alternative to autografts and allografts [6]. Advances in human stem cell research
demonstrate that these cells have unique properties that are important for the development of
engineered tissue constructs, including high proliferation rates and self-renewal capacity,
maintenance of the unspecialized state, and specialized differentiation under given
conditions. Human mesenchymal stem cells (hMSCs) isolated from either adult bone
marrow or adipose tissue possess a high capacity for self-replication and have the potential
to differentiate into osteogenic, chondrogenic, adipogenic and tenogenic lineages when
placed in an appropriate environment [7,8].
The interaction and metabolism of Ag-NPs with cultured osteoblasts grown from hMSC
should be minimal for their incorporation into a scaffold to be successful. A number of
studies have shown that various mesoporous silica and magnetic NPs used for cell tracking
have no apparent deleterious effects on the morphology, cell proliferation, cell viability and
differentiation efficiency of stem cells [9–11]. However, Ag-NPs and Ag ions have been
reported to attach to cell membranes, and interact with cellular molecules such as DNA,
bacterial cell wall components or sulfhydryl groups of metabolic enzymes [2–4]. Therefore,
bacterial replication, membrane permeability, and different metabolic pathways may be
interrupted. The objective of this study was to evaluate the toxicity and cellular uptake of
both undifferentiated and differentiated human adipose-derived stem cells (hASCs) exposed
to Ag-NPs, and to assess their potential effect on hASC differentiation. Understanding the
interactions between Ag-NPs and undifferentiated hASC is important to determine whether
the antimicrobial activity of Ag-NPs is detrimental to the differentiation of hASC down the
adipogenic or osteogenic pathways for tissue engineering scaffold systems.
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Two solutions of spherical Ag-NPs were obtained from NanoComposix (CA, USA), each at
Ag-NP concentration of 1.00 mg/ml with diameters of 10 and 20 nm. Ag-NPs were
synthesized by ammonium hydroxide-catalyzed growth of Ag onto 5-nm gold-seed particles.
Concentration of the particles was achieved via tangential flow filtration. The Ag-NPs were
then serially washed with 20 volume equivalents of phosphate buffer (PB), resuspended in
stabilizing citrate buffered deionized (DI) water and stored at 4°C in the dark.
Particle size was determined by dynamic light scattering (DLS) and transmission electron
microscopy (TEM) to confirm the manufacturer-identified diameters. To measure the
hydrodynamic diameters and the ζ-potential, samples of Ag-NPs were suspended at the
highest dosing concentration in DI water, immediately placed in a disposable cuvette and
analyzed using a Zetasizer Nano-ZS (Malvern Instruments, Inc., Worcestershire, UK). The
DLS readings were performed at the standard characterization temperature of 25°C. Each
measurement was repeated five-times, with ten to 20 runs as optimized by the instrument.
Data was culled based on the correlogram, size quality report and expert advice rendered by
the Dispersion Technology Software (5.03) (Malvern Instruments Inc.). In addition, TEM
was utilized to characterize Ag-NP structure, shape and size uniformity. Samples were
prepared by placing a drop of homogeneous suspension of each Ag-NP solution at the
highest dosing concentration in DI water onto a formvar-coated copper grid and air dried.
Samples were examined on an FEI™/Philips EM 208S (FEI, OR, USA) TEM operating at an
accelerating voltage of 80 kV.
hASC isolation & expansion
All protocols involving human tissue were approved by the Institutional Review Boards of
the University of North Carolina at Chapel Hill (NC, USA) and North Carolina State
University (NC, USA). Excess adipose tissue from elective plastic surgery procedures was
obtained with donor consent from five premenopausal female donors of Caucasian, Native
American or other ethnicities who ranged from 24 to 37 years of age. The hASC were
isolated from the adipose tissue by enzymatic digestion using 0.075% collagenase type I,
and characterized as described in [12,13]. Cells were seeded into T-75 flasks, and grown to
approximately 70–80% confluency in a 5% CO2 incubator at 37°C for expansion and
culture. Cells were harvested using trypsin which increased their passage number
incrementally (e.g., passage-0, passage-1 and so on). At passage-1, hASC from each of the
five donors were pooled into a T-75 flask (20,000 cells/donor; 100,000 cells total), expanded
and frozen in liquid nitrogen until needed.
Pooled passage-3 cells were seeded into T-75 cell culture flasks at 100,000 cells/flask,
cultured in complete growth medium (minimum essential medium eagle, alpha-modified
supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 100 units/ml penicillin and
100 μg/ml streptomycin), and maintained at 37°C in a humidified atmosphere of 5% CO2.
Once hASC reached 80% confluency, after 6 days, cultures were washed twice with
phosphate buffered saline and cells were retrieved using trypsin. At this point, hASC were
plated into 12-well plates (5000 cells/well) to assess viability, into T-25 flasks (50,000 cell/
flask) to assess cellular uptake, and into six-well plates (50,000 cells/well) to assess any Ag-
NP effects on differentiation. Differentiation of cells was achieved via hASC culture in
osteogenic medium (complete growth medium supplemented with 50 μM ascorbic acid, 0.1
μM dexamethasone and 10 mM β-glycerophosphate), or in adipogenic medium (complete
growth medium supplemented with 1 μM dexamethasone, 5 μg/ml insulin, 100 μM
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indomethacin and 500 μM isobutylmethylxanthine), or in complete growth medium to
maintain the cells in their progenitor cell state.
Cell viability
To determine the effect of Ag-NPs on both undifferentiated and differentiated hASC
viability, undifferentiated hASC were grown to 100% confluency in complete growth
medium for 4 days. To determine the baseline viability, hASC were first differentiated down
the osteogenic and adipogenic pathways or maintained in their proliferative state for 14 days
and then exposed for 24 h to concentrations of 0, 0.1, 1.0, 10.0, 50.0 and 100.0 μg/ml of
either 10- or 20-nm Ag-NPs. As a comparison to examine any effect internalized Ag-NPs
have on hASC, cells were first exposed for 24 h to Ag-NPs and then differentiated down the
osteogenic or adipogenic pathways (or maintained in their proliferative state) for 14 days. At
the conclusion of each of these alternatives, the viability of the hASC was assessed with
alamarBlue® (Molecular Probes, Invitrogen, OR, USA) viability assay; this assay was
chosen based upon its dye having minimal interactions with Ag-NPs [14]. Briefly, a 10%
alamarBlue solution was added to each well, incubated for 3 h and fluorescence quantitated
on a Spectra Max® Gemini™ (Molecular Devices, CA, USA) EM spectro photometer at an
excitation wavelength of 545 nm and an emission wavelength of 590 nm. The fluorescence
values were normalized to controls and expressed as percent viability.
Cellular uptake
To view potential cellular uptake of Ag-NPs into hASC, undifferentiated hASC were grown
to 100% confluency in complete growth medium for 5 days. To determine baseline uptake
data, hASC were first differentiated down the osteogenic or adipogenic pathways or
maintained in their proliferative state for 14 days and then exposed for 24 h to
concentrations of 0, 0.1, 1.0, 10.0, 50.0 and 100.0 μg/ml of either 10- or 20-nm Ag-NPs. As
a comparison to examine any morphological and ultrastructural effect internalized Ag-NPs
have on hASC, cells were first exposed for 24 h to Ag-NPs and then differentiated down the
osteogenic or adipogenic pathways (or maintained in their proliferative state) for 14 days. At
the conclusion of each of these alternatives, cells were harvested with trypsin, rinsed in
Hank’s balanced salt solution and fixed for 24 h in Trump’s fixative at 4°C. Cells were
rinsed in 0.1 M PB (pH 7.2), pelleted in a microfuge tube, resuspended and quickly pelleted
in 3% molten agar. Samples were postfixed in 1% osmium tetroxide in 0.1 M PB for 1 h at
4°C, washed with DI water, dehydrated through an ascending ethanol concentration, cleared
in acetone, infiltrated and embedded with Spurr’s resin, and polymerized at 70°C overnight.
Cells were not stained to allow for better visualization of the Ag-NPs and to ensure the
absence of stain precipitate artifacts. TEM analysis was performed to determine if any
morphological or ultrastructural changes occurred between untreated cells and cells exposed
to Ag-NPs either prior to or following differentiation, as well as any abnormalities in
intracellular lipid accumulation within adipogenic cells or extracellular calcium accretion by
osteogenic cells.
Effects on differentiation
To assess any effects of Ag-NPs on hASC differentiation, undifferentiated hASC were
grown to 100% confluency in complete growth medium for 5 days. Then, hASC were
exposed for 24 h to either 10- or 20-nm Ag-NPs at concentrations of 0, 0.1, 1.0, 10.0, 50.0
and 100.0 μg/ml, made fresh in complete growth medium. After 24 h the medium was
removed, and cells were differentiated down the osteogenic or adipogenic pathways or
maintained in their proliferative state for 14 days. Osteogenic differentiation was determined
with Alizarin Red S staining for extracellular calcium accretion, and adipogenic
differentiation was determined with Oil Red O staining for intercellular lipid accumulation.
To assess differences in staining between control and treatment wells, digital light
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microscopy images were obtained from each well (n = 6 wells per treatment), and the pixel
area per image (three images per well) covered by the stained calcium or lipid was
determined by color-based image analysis using Adobe® Photoshop®.
Statistical analysis
The mean values for hASC percent viability (normalized to control) and pixel area per
image for each treatment were calculated, and the significant differences (p < 0.05)
determined by the PROC GLM Procedure (SAS 9.1 for Windows; SAS Institute, NC, USA).
When significant differences were found, multiple comparisons were performed with the
Tukey’s Studentized Range HSD test at p < 0.05 level of significance. The Dunnett’s t-test
was performed to determine the significance at p < 0.05 of differences between control and
treatment groups. Data were expressed as the mean ± standard error of the mean of two
plates (n = 6 wells per treatment) and three images per treatment.
Results
Ag-NP characterization
The physicochemical properties of the Ag-NPs can be found in Table 1, which lists the
physical and hydrodynamic diameters of the Ag-NPs according to TEM and DLS,
respectively, as well as the supplied Ag-NP solution concentration, particle concentration
and ζ-potential. As is typical for nanomaterials, the hydrodynamic diameter of the 10- and
20-nm Ag-NPs measured by DLS was found to be slightly larger (21.7 and 27.4 nm,
respectively) than the physical diameter measured by TEM (7.2 and 19.2 nm, respectively).
The significantly larger hydrodynamic diameter of the 10-nm Ag-NPs is most likely
attributable to the formation of small, loosely bound Ag-NP dimers. The ζ-potential of a
colloid characterizes its stability and ability to resist aggregation, with greater ζ-potentials
having greater stability. Both the 10- and 20-nm Ag-NPs had ζ-potentials between −40 and
−50 eV, which indicated good stability. The stability and lack of aggregated clusters is
largely due to the addition of stabilizing citrate buffer. According to TEM, both 10- and 20-
nm Ag-NPs were found to be spherical in shape and highly uniform in size (Figure 1).
Cell viability
When undifferentiated hASC were exposed to 10- and 20-nm Ag-NPs for 24 h, and then
differentiated for 14 days, no significant decrease in viability was observed for the
undifferentiated hASC. A concentration-dependent toxicity was observed for both
osteogenic and adipogenic cells starting at an Ag-NP concentration of 10 μg/ml (Figure 2A
& B). Similarly, the addition of either 10- or 20-nm Ag-NPs following hASC differentiation
resulted in no significant decrease in viability of undifferentiated hASC at any
concentration, while concentration-dependent toxicity was observed for 10-nm Ag-NPs at
100 μg/ml for osteogenic cells and at 10 μg/ml for adipogenic cells (Figure 2C), and for 20-
nm Ag-NPs at 50 μg/ml for osteogenic cells and at 100 μg/ml for adipogenic cells (Figure
2D). It should be noted that although significant decreases in viability were observed, the
maximal loss of viability was only 30%.
Cellular uptake
Exposure of 10- and 20-nm Ag-NPs to differentiated hASC served as the control for the
evaluation of 10- and 20-nm Ag-NP exposure to undifferentiated hASC. Any morphological
and ultrastructural changes in cells, as well as changes in intracellular lipid accumulation in
adipogenic cells and extracellular calcium accretion in osteogenic cells, were compared with
untreated cells. It was observed that for each treatment group, approximately 50% of all
cells contained Ag-NPs within their cytoplasmic vacuoles, and an increase in treatment
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concentration resulted in an increase in Ag-NP agglomerates within the vacuoles.
Transmission electron micrographs of cells exposed to 10 μg/ml are shown as a
representative sample (Figures 3–5).
Neither 10- nor 20-nm Ag-NP exposure to either undifferentiated or differentiated hASC
resulted in any morphological abnormalities to cells compared with controls. Control hASC
were slightly elongated and displayed indented nuclei, a prominent nucleolus and small
intra-cytoplasmic vacuoles along the periphery of the nucleus (Figure 3A). Small
agglomerates of 10-nm Ag-NPs were observed at low magnification within cytoplasmic
vacuoles of hASC (Figure 3B), and high magnification of these vacuoles confirmed the
presence of Ag-NPs through the highly uniform shape and size of the Ag-NPs (Figure 3C).
Similarly, 20-nm Ag-NPs were seen in small agglomerates within vacuoles along the
periphery of the nucleus (Figure 3D). High magnification confirmed numerous Ag-NPs
within these vacuoles (Figure 3E).
Both 10- and 20-nm Ag-NP exposure to hASC prior to, or following, adipogenic
differentiation did not result in any morphological or ultrastructural changes to cells
compared with controls. Control adipogenic cells exhibited a more globular morphology
with extensive lipid droplet accumulation within the cell (Figure 4A). Small agglomerates of
10-nm Ag-NPs were observed at low magnification within cytoplasmic vacuoles of
unstained adipogenic cells, and Ag-NPs were not observed within the lipid droplets (Figure
4B). High magnification of these vacuoles confirmed the presence of Ag-NPs through the
highly uniform shape and size of the Ag-NPs (Figure 4C). Similarly, 20-nm Ag-NPs were
seen in small agglomerates within cytoplasmic vacuoles (Figure 4D), and high
magnification again confirmed Ag-NPs within these vacuoles (Figure 4E).
Both 10- and 20-nm Ag-NP exposure to hASC prior to, or following, osteogenic
differentiation did not result in any morphological changes to the cells compared with
controls. Control osteogenic cells were more fusiform (Figure 5A), with extensive
extracellular calcium accretion (Figure 5B). Numerous small agglomerates of 10-nm Ag-
NPs were observed at low magnification within cytoplasmic vacuoles of the osteogenic cells
(Figure 5C), and high magnification of these vacuoles confirmed the presence of Ag-NPs
through the highly uniform shape and size of the Ag-NPs (Figure 5D). Similarly, 20-nm Ag-
NPs were seen in small agglomerates within vacuoles (Figure 5E), and high magnification
confirmed Ag-NPs within these vacuoles (Figure 5F).
Effects on differentiation
Exposure of undifferentiated hASC to either 10 or 20-nm Ag-NPs for 24 h at any
concentration did not influence hASC differentiation. Light micrographs of cells exposed to
10 μg/ml are shown as a representative sample (Figures 6–8).
Undifferentiated hASC were stained for calcium accretion with Alizarin Red S (Figure 6A–
C), and lipid accumulation with Oil Red O (Figure 6D–F). Since the hASC were maintained
in complete growth medium, control cells stained for neither calcium (Figure 6A) nor lipid
(Figure 6D). There was no significant occurrence of either lipid or calcium following
exposure to 10-nm Ag-NPs at any of the concentrations as evidenced by a lack of calcium
and lipid staining (Figures 6B & E). These results were consistent for 20-nm Ag-NPs
(Figures 6C & F).
Adipogenic cells were stained for calcium accretion with Alizarin Red S (Figures 7A–C),
and lipid accumulation with Oil Red O (Figures 7D–F). Control adipogenic cells did not
stain for calcium (Figure 7A) and stained strongly for lipid (Figure 7D). There was no
significant change in lipid accumulation or calcium accretion following exposure to 10-nm
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Ag-NPs at any concentration as evidenced by the continued lack of calcium staining (Figure
7B) and continued strong lipid staining (Figure 7E). Similarly, exposure to 20-nm Ag-NPs at
any concentration did not influence the differentiation down the adipogenic pathway, as
evidenced by the continued lack of calcium staining (Figure 7C), and continued strong lipid
staining (Figure 7F).
Osteogenic cells were stained for calcium accretion with Alizarin Red S (Figures 8A–C),
and lipid accumulation with Oil Red O (Figures 8D–F). Control osteogenic cells stained
strongly for calcium (Figure 8A) and did not stain for lipid (Figure 8D). There was no
significant change in lipid accumulation or calcium accretion following exposure to 10-nm
Ag-NPs at any concentration as evidenced by the continued strong calcium staining (Figure
8B) and continued lack of lipid staining (Figure 8E). Similarly, exposure to 20-nm Ag-NPs
at any concentration did not influence the differentiation down the osteogenic pathway, as
evidenced by the continued strong calcium staining (Figure 8C), and continued lack of lipid
staining (Figure 8F).
Discussion
Bone grafts are the second most transplanted material, second only to blood transfusions
[15]. Currently, conventional treatment methods for bone replacement are limited to
autografts (grafts derived from the patient), and allografts (grafts derived from a donor).
While autografts are the most desirable option due to the significantly reduced immune
reaction, patients possess a relative lack of supply. The use of cadaverous allografts provides
a larger tissue supply but may cause immunological reactions. Alternatively, hASC are
capable of providing patient-specific cells for tissue regeneration therapies due to their high
proliferation rates and self-renewal capacity, maintenance of the unspecialized state,
migration capability and specialized differentiation into various cell types such as bone,
cartilage, fat and muscle. This differentiation may be achieved through chemical induction;
however, differentiation may also be influenced by the material properties of the tissue-
engineered scaffolds onto which they are seeded.
Every year approximately 300,000 patients who have undergone surgery suffer from
surgical-site infection [101]. Studies investigating the effects of surgical-site infection have
estimated that an infection increases patient stay by an additional 5 days at a cost of nearly
US$18,000 per patient, bringing the yearly cost of surgical-site infection patient care to over
$10 billion [101]. Therefore, while the development of tissue engineering of patient-specific
bone grafts have become a viable alternative to autografts and allografts, the implantation of
these tissue grafts would still suffer from the high rate of surgical-site infection. To
overcome this, once an optimal scaffolding material is achieved for each tissue type,
antimicrobial activity to prevent infection could be achieved through the incorporation of
Ag-NPs. The indiscriminate activity of Ag-NPs and the released ions would provide broad-
spectrum antimicrobial activity to scaffolding, and decrease the rate of incidence of infection
while improving the success rate and ultimate feasibility of tissue-engineered grafts. In
addition, this would help to decrease the widespread use of prophylactic antibiotics that has
increased the occurrence of bacterial resistance to typical antibiotics such as methicillin.
Therefore, the interaction and metabolism of Ag-NPs with hASC should be minimal for
their incorporation into a scaffold to be successful. However, the biocompatibility of Ag-
NPs with hASC is a prerequisite to their incorporation into scaffolding. Therefore, this study
validated the use of Ag-NP incorporation into a tissue-engineered scaffold by assessing the
toxicity, cellular uptake and effect on hASC differentiation following exposure to either 10-
or 20-nm Ag-NPs at concentrations of 0.1, 1.0, 10.0, 50.0 and 100.0 μg/ml both prior to, and
following, hASC differentiation down their adipogenic and osteogenic pathways.
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Fortunately, there are a number of studies that have shown that internalized NPs have no
apparent deleterious effects on the morphology, cell proliferation, cell viability and
differentiation efficiency of mesenchymal stem cells [9,10]. Studies involving easily
functionalized polystyrene and silica NPs and derivatized magnetic NPs used for biomedical
imaging, drug delivery and gene therapy have shown that their internalization into hASC
does not illicit cytotoxicity [9–11,16]. Multiwalled carbon nanotubes incorporated into
tissue engineered scaffolding were not shown to affect the viability or proliferation of hASC
[17]. In addition, NPs composed of osteogenic factors have shown remarkable
improvements in mesenchymal stem cell adhesion, attachment and differentiation on tissue-
engineered bone scaffolds [18].
The results of this study were similar to our previous research which showed that washed
20-, 50- and 80-nm Ag-NPs did not cause a decrease in viability to human epidermal
keratinocytes [14]. This study determined that metallic NPs such as Ag-NPs are capable of
interfering with viability assay dye and dye products through the adsorption of cell medium
constituents and cytokines, which is a common effect and has been reported for several other
viability assays and nanomaterials [19–21]. Based upon these findings, alamarBlue was
chosen for this study due to its limited interaction with Ag-NPs. These same Ag-NPs have
already been evaluated for their antibacterial efficacy in a previous study, and were found to
inhibit the growth of both Gram-positive and Gram-negative bacterial strains such as E. coli,
S. aureus, methicillin-resistant S. aureus and Salmonella, beginning at approximately 64 μg/
ml. In the same study, AgNO3 was used as a positive control for Ag ions and was shown to
inhibit the strains at 1.7 μg/ml, indicating that the 64 μg/ml inhibitory concentration of Ag-
NPs released at least an equivalent 1.7 μg/ml of Ag+. Therefore, the concentrations used in
the present study were chosen to encompass the bacterial inhibitory concentration [2].
There is a general agreement that dissolved Ag ions are responsible for the biocidal activity
that is especially pronounced against microorganisms, and this ability of Ag-NPs to slowly
release these ions from their surface has made them an attractive antimicrobial additive to
products. The rate of dissolution is obviously a complicated process that is dependent upon
many factors including the method of Ag-NP synthesis, storage length before use,
temperature, light exposure, surface functionalization and cell culture conditions [22]. The
biological activity of freshly prepared and aged Ag-NPs is remarkably different due to the
different amounts of released ions. For example, in a study that utilized hASC as reporter
cells to analyze the effect on cell viability and morphology from the release of Ag ions over
time from 50 ± 20 nm citrate-stabilized Ag-NPs, it was found that 25 μg/ml of 3-day-old
Ag-NPs were enough to cause a decrease in viability to 70%, compared with a complete loss
of viability for Ag-NPs first aged in water for 1–6 months [22]. Similarly, 8-nm Ag-NPs in
DI water were shown to release less than 0.1 μg/ml of Ag ions after 1 day of incubation and
up to 2 μg/ml after 120 days of incubation, while dissolution rates decreased with the
addition of citrate stabilization or in the presence of organic matter [23]. In addition, the
investigators showed that their release rates were congruent with commercial Ag-NPs
stabilized with gelatin and gum Arabic, similar to previous reports [23,24].
Axiomatically, the lethal concentration of Ag-NPs will be higher than that of Ag+ due to the
limited release rate of Ag+ from the surface of the particles. The lethal concentration of Ag+
to human cell lines such as germline stem cells, dermal fibroblasts and leukocytes is
generally below 5 μg/ml, so it is questionable that many papers report toxicity of Ag-NPs at
the same concentration of reported toxicity of Ag+ alone [23–27]. For example, 15-nm Ag-
NPs synthesized in a pulsed-plasma reactor have also caused toxicity in germline stem cells
at 10 μg/ml [24]. Controversy concerning the concentration of Ag-NP toxicity is most likely
due to the Ag-NP synthesis method, whether or not the Ag-NPs are washed, and their length
of storage prior to use. Ag-NP solutions may contain residual reducing agent contaminants
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that are known toxicants, a finding confirmed in this laboratory where the presence of
formaldehyde in freshly synthesized Ag-NP solutions was found to be responsible for the
toxicity in skin cells compared with thoroughly washed Ag-NPs [14]. The citrate
stabilization of the 10- and 20-nm Ag-NPs used in this study may explain their higher lethal
concentration, which is congruent with the rare studies that explicitly state that when
particles are washed they result in higher lethal concentrations compared with studies that do
not mention washing, generally greater than 25 μg/ml [14,22,28,29].
The results of this study demonstrate that exposure of 10- and 20-nm Ag-NPs either prior to
differentiation, or following 14 days of hASC differentiation, resulted in no significant cyto-
toxicity to hASC, and minimal dose-dependent toxicity to adipogenic and osteogenic cells at
10 μg/ml and greater. Drawing on the results of the previous bacterial study, it is reasonable
to conclude that at least 1.7 μg/ml was released from the Ag-NPs at the highest
concentration of 100 μg/ml and resulted in increased cell toxicity. In each of the analyses
where the hASC were first exposed to Ag-NPs and then differentiated, residual Ag-NPs
remained attached to the cells throughout the 14 days of differentiation, which was
confirmed by TEM. This is particularly relevant; since degradable tissue-engineered
scaffolds containing Ag-NPs will shed these NPs and their ions over the course of the
scaffold lifetime to impart their antimicrobial activity, and will therefore interact with the
seeded progenitor cells over the course of their differentiation. Each of the progenitor,
adipogenic and osteogenic cells showed cellular uptake of both 10- and 20-nm Ag-NPs,
without eliciting any abnormal morphological or ultrastructural changes. Lastly, exposure to
10- and 20-nm Ag-NPs for 24 h did not influence the intended differentiation of the
undifferentiated hASC, adipogenic or osteogenic cells, and at the antibacterial concentration
of 64 μg/ml, the Ag-NPs showed minimal toxicity.
Conclusion & future perspective
This study showed that exposure of hASC to 10- and 20-nm Ag-NPs either prior to
differentiation, or following 14 days of differentiation, resulted in no significant cytotoxicity
to undifferentiated hASC. Minimal dose-dependent toxicity was observed for adipogenic
and osteogenic cells at concentrations of 10 μg/ml and greater. The cellular uptake of Ag-
NPs into each of the hASC, osteocytes and adipocytes did not alter their ultrastructural
morphology, or influence hASC differentiation. Exposure of 10- and 20-nm Ag-NPs at
concentrations up to 100 μg/ml did not influence hASC differentiation. Although the cell
quantity limited this study to the investigation of the effect of Ag-NPs on cell viability,
uptake and differentiation, these results conclude that either 10- or 20-nm Ag-NPs are
suitable to incorporate into tissue-engineered scaffolds that utilize hASC.
Further studies may be conducted to ensure the biocompatibility of the Ag-NPs with hASC,
including assays for hASC immunophenotype preservation or DNA stability, cytokine
release, or the effects of multiple Ag-NP exposures during differentiation. These results are
promising for future studies where Ag-NPs will be incorporated into tissue-engineered
scaffolds. Previously evaluated scaffolding for bone graft therapies comprised of collagen,
collagen coated poly(ε-caprolactone) and poly(L-lactic acid)/tricalcium phosphate
nanofibers has been shown to increase cell-mediated calcium accretion [30–32], and would
be a suitable model to evaluate Ag-NP incorporation. The addition of antimicrobial
functionality, namely through the incorporation of Ag-NPs into a tissue-engineered graft
scaffold would be pivotal in preventing bacterial growth and thereby minimizing infections,
as well as patient and hospital costs.
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• Exposure of 10- and 20-nm silver (Ag)-nanoparticles (NPs) either prior to
differentiation, or following 14 days of human adipose-derived stem cell
(hASC) differentiation, resulted in no significant cytotoxicity to hASC. Minimal
dose-dependent toxicity was observed for adipogenic and osteogenic cells at
concentrations of 10 μg/ml and greater.
• Exposure of 10- and 20-nm Ag-NPs either prior to differentiation, or following
14 days of hASC differentiation, resulted in cellular uptake into each of the
progenitor, adipogenic and osteogenic cells, without eliciting ultrastructural
alterations.
• Exposure of 10- and 20-nm Ag-NPs for 24 h did not influence the intended
differentiation of the cells.
• Ag-NPs are suitable for tissue-engineered scaffolding incorporation at the
antibacterial concentration of 64 μg/ml.
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Figure 1. Transmission electron micrographs of silver nanoparticles
(A) 10 nm and (B) 20 nm. Scale bars: 50 nm.
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Figure 2. alamarBlue® viability of undifferentiated and differentiated human adipose-derived
stem cells exposed to silver nanoparticles
alamarBlue viability of undifferentiated human adipose-derived stem cells, treated with
either (A) 10 or (B) 20 nm Ag-NPs and then differentiated for 14 days; human adipose-
derived stem cells differentiated for 14 days and then treated with (C) 10 or (D) 20-nm Ag-
NPs.
†Significant differences (p < 0.05) in viability were assessed by multiple comparisons
between concentrations, per cell pathway.
Ag: Silver; NP: Nanoparticle.
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Figure 3. Transmission electron micrographs of human adipose-derived stem cells exposed to
either 10- or 20-nm silver nanoparticles at 10 μg/ml
(A) Human adipose-derived stem cells (hASCs); (B) hASC treated with 10-nm silver
nanoparticles (Ag-NPs); (C) higher magnification of vacuole containing Ag-NPs from (B);
(D) hASC treated with 20-nm Ag-NPs and (E) higher magnification of vacuoles containing
Ag-NPs from (D). Scale bars: 2 μm (A, B & D); scale bars: 200 nm (C & E). Arrows
denote agglomerates of Ag-NPs.
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Figure 4. Transmission electron micrographs of adipogenic cells exposed to either 10- or 20-nm
silver nanoparticles at 10 μg/ml
(A) Adipogenic cell showing spherical lipid accumulation; (B) adipogenic cell treated with
10-nm silver nanoparticles (Ag-NPs); (C) higher magnification of the vacuole containing
Ag-NPs from (B); (D) adipogenic cell treated with 20-nm Ag-NPs and (E) higher
magnification of the vacuole containing Ag-NPs from (D). Scale bars: 2 μm (A, B & D);
scale bars: 200 nm (C & E). Arrows denote agglomerates of Ag-NPs.
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Figure 5. Transmission electron micrographs of osteogenic cells exposed to either 10- or 20-nm
silver nanoparticles at 10 μg/ml
(A) Osteogenic cell showing extracellular calcium accretion (dark dots); (B) higher
magnification of accreted calcium; (C) osteogenic cell treated with 10-nm silver
nanoparticles (Ag-NPs); (D) higher magnification of the vacuole containing Ag-NPs from
(C); (E) adipogenic cell treated with 20-nm Ag-NPs and (F) higher magnification of the
vacuole containing Ag-NPs from (E). Scale bar: 5 μm (A); scale bars: 2 μm (B, C & E);
scale bars: 200 nm (D & F). Arrows denote agglomerates of Ag-NPs.
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Figure 6. Light micrographs of undifferentiated human adipose-derived stem cells exposed to
either 10- or 20-nm silver nanoparticles at 10 μg/ml
(A–C) No stain for either calcium accretion with Alizarin Red S or for (D–F) lipid
accumulation with Oil Red O. Human adipose-derived stem cells (A & D) exposed to 10-nm
silver nanoparticles (Ag-NPs) (B & E), or 20-nm Ag-NPs (C & F). Scale bars: 0.1 mm.
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Figure 7. Light micrographs of adipogenic cells exposed to either 10- or 20-nm silver
nanoparticles at 10 μg/ml. (A–C)
No stain for calcium accretion with Alizarin Red S and (D–F) strong staining for lipid
accumulation with Oil Red O (cherry red spots). Control cells (A & D) exposed to 10-nm
silver nanoparticles (Ag-NPs) (B & E), or 20-nm Ag-NPs (C & F). Scale bars: 0.1 mm.
Samberg et al. Page 20













Figure 8. Light micrographs of osteogenic cells exposed to either 10- or 20-nm silver
nanoparticles at 10 μg/ml. (A–C)
exhibits strong staining for calcium accretion with Alizarin Red S (red spots) but none for
(D–F) lipid accumulation with Oil Red O. Control cells (A & D) exposed to 10-nm silver
nanoparticles (Ag-NPs) (B & E) or 20-nm Ag-NPs (C & F). Scale bars: 0.1 mm.
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